Plasma glucose Hypoglycemia Insulin End stage renal disease Type 2 diabetes Insulin Hemodialysis Glycemic control Type 2 diabetes (T2DM)
Conditions
Interventions
Patients should be treated with an adjusted dose of insulin (25% decrease of prescription). ,Patients should be treated with an unadjusted dose of insulin (100% of prescription).
Experimental Drug,Active Comparator Drug
adjusted insulin dose,nonadjusted insulin dose
Sponsors
Phramongkutklao Hospital and College of Medicine
Phramongkutklao Hospital and College of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria comprised being 18 years or older, diagnosis of T2DM, on hemodialysis three sessions weekly and for at least three months, stable insulin dosage for at least three months and stable glycemic treatment with HbA1c<8% for at least three months
Exclusion criteria
Exclusion criteria: Exclusion criteria included diagnosis of type 1 diabetes, pregnancy, active malignancy, being physically-challenged, active or chronic infection within three months of starting the study and symptomatic hypo- or hyperglycemia within three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fasting plasma glucose 8 weeks biochemistry test | — |
Secondary
| Measure | Time frame |
|---|---|
| hypoglycemic symptoms 8 weeks clinical assessment and plasma glucose | — |
Countries
Thailand
Contacts
Public ContactBancha Satirapoj
Phramongkutkloa Hospital
Outcome results
None listed